Intelligence ecosystem
AI Healthcare Intelligence for Global Life Sciences
One interconnected AI intelligence ecosystem. Transforming decisions across healthcare and life sciences.
Explore HERMS IntelligenceAGENTIC AI FOR HEALTHCARE & LIFE SCIENCES
HERMS gives health authorities, pharmaceutical companies, biotechnology firms, and medical technology manufacturers one place to connect scientific evidence with the decisions that follow it, in every market where they operate.
Evidence connected. Decisions traceable. People accountable.
Intelligence ecosystem
One interconnected AI intelligence ecosystem. Transforming decisions across healthcare and life sciences.
Explore HERMS IntelligenceThe HERMS platform
HERMS connects evidence and decisions across advanced therapies, clinical development, manufacturing, regulatory affairs, market access, patient safety and compliance.
Explore HERMS solutionsLife Sciences Expertise
Regional & Global Reach
Advanced Innovation Platforms
FIRST-IN-CLASS Intelligence Solutions
Protect Prices. Optimize Market Value.
Predict Disruptions. Protect Product Availability.
Prevent Costly Failures. Protect Business Integrity.
Detect Safety Signals Earlier. Strengthen Oversight.
Maximize Public Spending Efficiency. Reduce Costs. Deliver Greater Value.
Unlock New Markets. Accelerate Sales.
Anticipate Gaps. Reduce Submission Risks.
Reduce Transfer Risks. Improve Production Readiness.
Attracting Advanced Therapies
Building National Capabilities
Accelerating Life-Saving Innovation
Strengthening Supply Resilience
Enabling Evidence-Led Decisions
Design Better Products. Accelerate Development.
Allocate Capital with Evidence.
Verify Every Claim. Defend Every Decision.
HERMS knowledge centre
Explore life sciences intelligence for pharmaceutical, biotechnology and medical device teams worldwide, with practical resources for market entry, patient safety and AI-enabled workflows, including dedicated UAE and GCC guides.
Navigate the next frontier of medicine. Track gene-editing platforms, cell and gene therapies, clinical breakthroughs and manufacturing hurdles to assess scientific promise and commercial potential.
Connect breakthrough science with commercial opportunity. Identify licensable assets, assess technology readiness and map strategic partners to guide licensing, co-development and technology-transfer decisions.
Build the case for access. Decode HTA, reimbursement, pricing and payer priorities to sharpen evidence strategies, strengthen value propositions and unlock commercial opportunities.
See the competition. Spot the opportunity. Track emerging assets, clinical milestones, product launches and competitor moves to identify market gaps and sharpen portfolio decisions.
Find value beyond the headline. Assess companies, therapeutic assets, funding activity and deal benchmarks to strengthen due diligence, target acquisitions and inform capital allocation.
Turn technical innovation into market opportunity. Decode classification, clinical evidence, approval pathways and reimbursement requirements to guide device, diagnostic and digital-health commercialization.
Anticipate change. Accelerate market entry. Track regulatory shifts, approval pathways and compliance requirements across pharmaceuticals, medical devices and cosmetics—turning complex rules into clear strategic action.
Compete where healthcare buying decisions happen. Track public tenders, purchasing priorities, qualification requirements and award patterns to target opportunities and sharpen bid strategy.
Build market-ready beauty portfolios. Track ingredient restrictions, safety standards, claims requirements and category trends to guide formulation, product positioning and cross-border expansion.
ENGINEERING INTELLIGENCE. REVOLUTIONIZING LIFE SCIENCES.
We use essential cookies to run this website and, with your consent, analytics cookies to improve it. You can change your choice at any time. Cookie Policy · Privacy Policy
HERMS is the intelligence platform. Its applications are the decision engines. HERMS expert services support implementation and regulated execution of the HERMS intelligence ecosystem, from regulatory and market access to pharmacovigilance, compliance and quality.